Medical Health Cluster


Novavax COVID Jab Approved by MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has today given conditional marketing authorisation (CMA) to Nuvaxovid, a COVID-19 vaccine developed by Novavax. It becomes the fifth COVID jab to which the MHRA has given regulatory approval. In the UK phase 3 trial, with over 15,000 participants, overall efficacy was […]

Read More